---
figid: PMC11201617__biomolecules-14-00656-g001
figtitle: Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in
  Target Treatments—An Overview
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11201617
filename: biomolecules-14-00656-g001.jpg
figlink: /pmc/articles/PMC11201617/figure/F1
number: F1
caption: 'Signaling pathways activated by growth factors: the interaction of the growth
  factors with their specific receptors triggers the molecular cascade of PI3K/AKT/mTOR
  and RAS/RAF/MERK/ERK, which results in the transcription (arrow) of genes responsible
  for maintaining cell survival and stimulating cell proliferation, migration, and
  angiogenesis. TGF-β—transforming growth factor-β; EGF—epidermal growth factor; IGF
  I/II—insulin-like growth factor I/II; VEGF—vascular endothelial growth factor; FGF—fibroblast
  growth factor; HGF—hepatocyte growth factor; EGFR—epidermal growth factor receptor;
  IGFR I/II—insulin-like growth factor receptor I/II; VEGFR—vascular endothelial growth
  factor receptor; FGFR—fibroblast growth factor receptor; c-Met—mesenchymal–epithelial
  transition factor; SMAD—Sma gene and the Drosophila MAD (Mothers against decapentaplegic);
  PI3K—phosphoinositide 3-kinases; PIP2—phosphoinositide phosphatidylinositol 4,5-bisphosphate;
  PIP3—phosphatidylinositol-3,4,5-trisphosphate; AKT—serine/threonine-specific protein
  kinase (AKR mouse strain that develops spontaneous thymic lymphomas); mTOR—mammalian
  target of rapamycin; RAS—rat sarcoma virus; RAF—rapidly accelerated fibrosarcoma;
  MEK—mitogen-activated protein kinase; ERK—extracellular signal-regulated kinase;
  AP-1—activator protein-1; c-Jun—Jun proto-oncogene; c-FOS—a proto-oncogene that
  is the human homolog of the retroviral oncogene v-fos; Elk-1—ETS transcription factor
  ELK1'
papertitle: Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and
  in Target Treatments—An Overview
reftext: Raluca-Margit Szilveszter, et al. Biomolecules. 2024 Jun;14(6).
year: '2024'
doi: 10.3390/biom14060656
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: hepatocellular carcinoma | TERT promoter mutation | p53 | WNT/β-catenin
  | telomere shortening | histone methylation | immune checkpoint inhibitors | tumoral
  microenvironment | exosomes
automl_pathway: 0.9517767
figid_alias: PMC11201617__F1
figtype: Figure
redirect_from: /figures/PMC11201617__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11201617__biomolecules-14-00656-g001.html
  '@type': Dataset
  description: 'Signaling pathways activated by growth factors: the interaction of
    the growth factors with their specific receptors triggers the molecular cascade
    of PI3K/AKT/mTOR and RAS/RAF/MERK/ERK, which results in the transcription (arrow)
    of genes responsible for maintaining cell survival and stimulating cell proliferation,
    migration, and angiogenesis. TGF-β—transforming growth factor-β; EGF—epidermal
    growth factor; IGF I/II—insulin-like growth factor I/II; VEGF—vascular endothelial
    growth factor; FGF—fibroblast growth factor; HGF—hepatocyte growth factor; EGFR—epidermal
    growth factor receptor; IGFR I/II—insulin-like growth factor receptor I/II; VEGFR—vascular
    endothelial growth factor receptor; FGFR—fibroblast growth factor receptor; c-Met—mesenchymal–epithelial
    transition factor; SMAD—Sma gene and the Drosophila MAD (Mothers against decapentaplegic);
    PI3K—phosphoinositide 3-kinases; PIP2—phosphoinositide phosphatidylinositol 4,5-bisphosphate;
    PIP3—phosphatidylinositol-3,4,5-trisphosphate; AKT—serine/threonine-specific protein
    kinase (AKR mouse strain that develops spontaneous thymic lymphomas); mTOR—mammalian
    target of rapamycin; RAS—rat sarcoma virus; RAF—rapidly accelerated fibrosarcoma;
    MEK—mitogen-activated protein kinase; ERK—extracellular signal-regulated kinase;
    AP-1—activator protein-1; c-Jun—Jun proto-oncogene; c-FOS—a proto-oncogene that
    is the human homolog of the retroviral oncogene v-fos; Elk-1—ETS transcription
    factor ELK1'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TGFB1
  - TGFB2
  - TGFB3
  - EGF
  - IGF1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - HGF
  - IL6
  - SOS1
  - EGFR
  - IGF1R
  - FCGR3A
  - KDR
  - FLT1
  - FLT4
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - MET
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - JUN
  - FOS
  - FOSB
  - JUNB
  - JUND
  - ELK1
  - KCNH4
  - KCNH8
  - EGF
  - collagen
---
